Shares of ACADIA Pharmaceuticals Inc. (NASDAQ:ACAD – Get Free Report) have earned a consensus recommendation of “Moderate Buy” from the sixteen ratings firms that are currently covering the stock, Marketbeat reports. Four investment analysts have rated the stock with a hold rating and twelve have issued a buy rating on the company. The average twelve-month […]
CNS Pharmaceuticals, Inc. (NASDAQ:CNSP – Get Free Report) saw a large increase in short interest during the month of May. As of May 15th, there was short interest totalling 62,500 shares, an increase of 100.3% from the April 30th total of 31,200 shares. Based on an average trading volume of 354,100 shares, the days-to-cover ratio […]
ACADIA Pharmaceuticals Inc. (NASDAQ:ACAD – Get Free Report)’s share price hit a new 52-week low during trading on Wednesday . The company traded as low as $14.60 and last traded at $14.68, with a volume of 628880 shares. The stock had previously closed at $15.09. Analyst Upgrades and Downgrades Several analysts recently weighed in on […]
ACADIA Pharmaceuticals Inc. (NASDAQ:ACAD – Get Free Report)’s stock price reached a new 52-week low during mid-day trading on Wednesday . The stock traded as low as $14.60 and last traded at $14.68, with a volume of 628880 shares traded. The stock had previously closed at $15.09. Analysts Set New Price Targets Several brokerages have […]
Quest Partners LLC acquired a new position in ANI Pharmaceuticals, Inc. (NASDAQ:ANIP – Free Report) during the fourth quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The institutional investor acquired 2,725 shares of the specialty pharmaceutical company’s stock, valued at approximately $150,000. Other institutional investors and hedge […]